证券记录 · 已归档季度
IONS
Ionis Pharmaceuticals, Inc. · Healthcare · Biotechnology
19被追踪持有人
+1Δ持有人
95.25M持有股份
$3.76B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +5.6% ·
股份流向 +0.1% ·
净新建仓位 +5.3%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 48.54K | $2.16M | n/a | −1 |
| Q2 2026 | 137 | +2 | 148.57M | $11.08B | +6 | −5 |
| Q1 2026 | 139 | -2 | 142.62M | $9.86B | +6 | −9 |
| Q4 2025 | 142 | 0 | 143.10M | $10.36B | +1 | n/a |
| Q3 2025 | 25 | +4 | 95.56M | $6.25B | +5 | −2 |
| Q2 2025 | 19 | +1 | 95.25M | $3.76B | +1 | n/a |
| Q1 2025 | 15 | -1 | 43.90M | $1.32B | +1 | −2 |
| Q4 2024 | 16 | -1 | 43.25M | $1.51B | n/a | −1 |
| Q3 2024 | 16 | -1 | 34.86M | $1.40B | n/a | −1 |
| Q2 2024 | 17 | n/a | 24.68M | $1.18B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 23.64M | n/a | $934.13M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | The Vanguard Group ✦ (被动) | 16.71M | n/a | $660.40M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Capital World Investors ✦ | 12.54M | +1.4% | $495.46M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 10.90M | n/a | $430.54M | 0.0% | n/c | 1 | SEC ↗ ×23 |
| 5 | Wellington Management ✦ | 6.35M | -24.6% | $250.72M | 0.0% | ▼ Trim | 5 | SEC ↗ ×9 |
| 6 | State Street Global Advisors ✦ (被动) | 4.53M | -6.5% | $179.00M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 7 | Adage Capital Partners ✦ | 3.80M | +253.3% | $150.14M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 3.13M | -4.3% | $123.51M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | Tweedy, Browne ✦ | 2.89M | -3.1% | $114.26M | 10.6% | ▼ Trim | 5 | SEC ↗ |
| 10 | Geode Capital Management ✦ (被动) | 2.89M | +1.7% | $114.25M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 2.65M | +317.0% | $104.68M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.79M | +6.1% | $70.66M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.49M | -57.0% | $59.07M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | ARK Investment Management ✦ | 900.32K | -10.0% | $35.57M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 15 | Norges Bank ✦ (被动) | 450.25K | -47.5% | $17.79M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 292.65K | +1.9% | $11.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 270.71K | +76.3% | $10.70M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 14.28K | 新增 | $564,163 | 0.0% | New | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 13.10K | +43.9% | $517,581 | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Gotham Asset Management | $564,163 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 490 持有人, 170.17M 股份, $11.94B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据